GGrantIndex
← Search

University of Colorado Cancer Center Support Grant

$115,000P30FY2021CANIH

University Of Colorado Denver, Aurora CO

Investigators

Linked publications, trials & patents

Paper 39763739Paper 39737640Paper 39726772Paper 39711559Paper 39711135Paper 39684443Paper 39677775Paper 39677720Paper 39677022Paper 39671500Paper 39671496Paper 39630148Paper 39609428Paper 39604567Paper 39603869Paper 39574899Paper 39564580Paper 39554114Paper 39436696Paper 39400608Paper 39384405Paper 39342284Paper 39321266Paper 39311710Paper 39282307Paper 39266537Paper 39264810Paper 39215796Paper 39201277Paper 39191549Paper 39147413Paper 39139560Paper 39136655Paper 39120971Paper 39091762Trial NCT05073848Trial NCT05053737Trial NCT05006040Trial NCT04993859Trial NCT04988490Trial NCT04973007Trial NCT04963283Trial NCT04940468Trial NCT04925193Trial NCT04922112Trial NCT04916990Trial NCT04882111Trial NCT04866758Trial NCT04863092Trial NCT04634110Trial NCT04611022Trial NCT04565457Trial NCT04558138Trial NCT04544592Trial NCT04541407Trial NCT04535102Trial NCT04520867Trial NCT04486573Trial NCT04471363Trial NCT04408092Trial NCT04305366Trial NCT04300478Trial NCT04294693Trial NCT04208243Trial NCT04092803Trial NCT04091867Trial NCT04066218Trial NCT04042935Trial NCT04035408Trial NCT04028167Trial NCT04028063Trial NCT04001101Trial NCT03995082Trial NCT03976193Trial NCT03970226Trial NCT03958565Trial NCT03900793Trial NCT03891654Trial NCT03881098Trial NCT03781154Trial NCT03734653Trial NCT03617679Trial NCT03325634Trial NCT01886859Trial NCT01426334Trial NCT01232829Trial NCT00778167Patent 9434994Patent 8734778Patent 8715649Patent 8343502Patent 8337830Patent 8221763Patent 8153136Patent 8067559Patent 7910315Patent 7595060Patent 7563447Patent 7465454Patent 7083787

Abstract

Abstract The UCCC is the only NCI-designated Cancer Center in Colorado and has as its catchment area the entire State of Colorado. There are conceptually two ?Colorados?: the Front Range (including the Denver metropolitan area along with a string of suburban and urban areas from Ft. Collins in the north to Pueblo in the south); and rural Colorado, where 23.1% of the population lives. The state is racially and ethnically diverse with Hispanics comprising 21.8% of the population in 2019 and residing throughout the state, where 22.1% of the urban population and 11.6% of the rural population are Hispanic. Colorado?s most isolated rural areas are home to the poorest Hispanics in the State. Likewise, Colorado?s African American population (4% of the total) is disproportionately poor and lives in isolated rural and frontier counties. Our National Outreach Network?s (NON) Community Health Educators (CHE) [NON-CHE] project organizes and conduct activities to reach all Coloradans, but in particular rural, Hispanic, and poverty-stricken populations. Through the NON-CHE project, we focus on educating communities about the importance of participating in CT and preventing cancers associated with the HPV with HPV vaccines. We also implement culturally tailored outreach activities to enhance community members? knowledge of, inquiry, and participation in locally available CT and HPV vaccinations. Our project focuses on identifying and referring community members to health care providers/institutions with available CT at affiliated institutions. For evaluation, we track the number of individuals referred to health care providers/institutions for CT participation with a 3-month post-referral follow-up to determine whether individuals accepted or declined CT participation and record reasons why individuals decided not to participate in a CT. Similarly, we conduct outreach to educate patients about the HPV vaccine and refer them to vaccination services in partnership with a Federally Qualified Health Center (FQHC) in Denver, Colorado. For both of our CT and HPV vaccine initiatives, we have developed and disseminate culturally, linguistically (English and Spanish), and literacy appropriate information to increase knowledge and awareness of racially/ethnically diverse communities. We also focus on providing information about treatment services and engaging patients in medical decision-making tailored to the individual patient. (i.e., risk and genetic predisposition). Last, we also provide community presentations for great reach and engagement. With this supplement extension we plan to continue our initiative by partnering with a rural FQHC that serves counties with increased cancer disparities to educate parents of adolescents (aged 11-18) and young adults (aged 19-26) about the importance of the HPV vaccine and navigate eligible patients to obtain the HPV vaccine doses need to complete their recommended HPV vaccine schedules. In addition, we will include an entertainment-education (E-E) video for parents and young adults to engage them in an evidence-based intervention to affect the precursors (e.g., intentions) to adopting of the HPV vaccine.

View original record on NIH RePORTER →